top of page
Search
Glenn Hearson
Aug 11, 2021
CF STORM a ground-breaking trial to assess management of CF patients daily healthcare routines
Dr Helen Barr of the NIHR Nottingham Biomedical Research Centre , will shortly commence recruitment into the CF STORM study at NUH...
81
Glenn Hearson
May 24, 2021
More positive results from #ANDHI study for Benralizumab in Severe Eosinophilic Asthma
The #ANDHI study, has recently had more results published in the European Journal of Allergy and Clinical Immunology " Benralizumab...
81
Glenn Hearson
Mar 31, 2021
SPRINTER Study a Phase 3 trial of SNG001 in patients hospitalised with Covid-19
Nottingham University Hospital NHS Trust and the NIHR Nottingham Biomedical Research Centre will shortly commence recruiting patients in...
712
Glenn Hearson
Mar 24, 2021
A year ago today NUH recruited their 1st patient into the worlds biggest #Covid19 treatment trial
It was one year ago today that Nottingham University Hospitals, using teams including those from the NIHR Nottingham BRC and...
85
Glenn Hearson
Jan 2, 2021
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
Benralizumab study ANDHI shows early clinical benefits in #severe asthma patient-reported outcomes
160
Glenn Hearson
Nov 17, 2020
APEX Asthma Exacerbation Studies Newsletter
Our APEX research studies looking into asthma attacks (exacerbations) new newsletter is now available. The APEX Studies are...
68
Glenn Hearson
Oct 5, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study
103
Glenn Hearson
Oct 5, 2020
The Nottingham Recovery from COVID-19 Research Platform Assessment Clinic
The Nottingham Recovery from COVID-19 Research Platform Assessment Clinic
321
bottom of page